Press release
Epidemic keratoconjunctivitis Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Epidemiology, Medication, and Companies by DelveInsight
Epidemic keratoconjunctivitis Treatment Market
(Albany, USA) DelveInsight's "Epidemic keratoconjunctivitis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Epidemic keratoconjunctivitis, historical and forecasted epidemiology as well as the Epidemic keratoconjunctivitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Epidemic keratoconjunctivitis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2020 to 2034. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Epidemic keratoconjunctivitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; [https://www.delveinsight.com/report-store/epidemic-keratoconjunctivitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Some of the key facts of the Epidemic keratoconjunctivitis Market Report:
* The Epidemic keratoconjunctivitis market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
* In 2023, there were approximately 2.8 million incident cases of viral conjunctivitis in the United States, with numbers expected to rise by 2034.
* In 2023, the total number of incident cases of epidemic keratoconjunctivitis in the 7MM was around 1.8 million.
* In 2023, the United States had approximately 1.3 million incident cases specific to adenovirus D, with this number projected to grow by 2034.
* Among the 7MM countries, Japan recorded the highest number of incident cases of epidemic keratoconjunctivitis, totaling approximately 1 million in 2023.
* In the EU4 and the UK, there were approximately 326,000 incident cases of epidemic keratoconjunctivitis, with Germany reporting the highest number and Spain the lowest.
* In 2023, the total number of incident cases of epidemic keratoconjunctivitis in the United States was approximately 510,000, with expectations for a decline by 2034.
* Key Epidemic keratoconjunctivitis Companies: Adenovir Pharma AB, and others
* Key Epidemic keratoconjunctivitis Therapies: APD-209 Eye drops, and others
* In May 2022 Santen Pharmaceutical received approval for Verkazia from the National Medical Products Administration (NMPA) in China through its legal entity for treating severe vernal keratoconjunctivitis (VKC) in children and adolescents aged four years and above.
* In March 2022, Visus Therapeutics Inc. announced the launch of the first of two pivotal phases 3 trials (BRIO-I and BRIO-II) for its lead asset, BRIMOCHOL PF, a topical preservative-free ophthalmic solution for treating presbyopia.
Epidemic keratoconjunctivitis Overview
Epidemic keratoconjunctivitis (EKC) is a highly contagious viral infection of the eye caused by adenoviruses. It affects the conjunctiva and cornea, leading to significant discomfort and potential vision impairment. EKC often occurs in outbreaks in healthcare settings, schools, or workplaces, spreading through direct contact with infected individuals, contaminated surfaces, or shared items like towels or eye drops.
Symptoms typically develop within 5-12 days of exposure and include redness, tearing, foreign body sensation, light sensitivity, and swelling of the eyelids. Watery discharge and preauricular lymphadenopathy (swollen lymph nodes near the ears) are common. Corneal involvement may result in blurred vision due to subepithelial infiltrates, which can persist for weeks or months.
Diagnosis is primarily clinical, based on symptoms and history, but viral cultures or PCR testing can confirm the infection in severe cases. There is no specific antiviral treatment for EKC; management focuses on symptomatic relief with lubricating eye drops, cold compresses, and sometimes corticosteroids for severe inflammation or corneal opacities.
Preventive measures are critical to controlling outbreaks, including strict hand hygiene, disinfecting surfaces, and avoiding direct contact with infected individuals. Early recognition and containment are essential to minimize transmission and protect vision.
Get a Free sample for the Epidemic keratoconjunctivitis Market Report: [https://www.delveinsight.com/report-store/epidemic-keratoconjunctivitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Epidemic keratoconjunctivitis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Epidemic keratoconjunctivitis Epidemiology Segmentation:
The Epidemic keratoconjunctivitis market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
* Total Prevalence of Epidemic keratoconjunctivitis
* Prevalent Cases of Epidemic keratoconjunctivitis by severity
* Gender-specific Prevalence of Epidemic keratoconjunctivitis
* Diagnosed Cases of Episodic and Chronic Epidemic keratoconjunctivitis
Download the report to understand which factors are driving Epidemic keratoconjunctivitis epidemiology trends @ [https://www.delveinsight.com/sample-request/epidemic-keratoconjunctivitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Epidemic keratoconjunctivitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Epidemic keratoconjunctivitis market or expected to get launched during the study period. The analysis covers Epidemic keratoconjunctivitis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Epidemic keratoconjunctivitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Epidemic keratoconjunctivitis Therapies and Key Companies
* APD-209 Eye drops: Adenovir Pharma AB
To know more about Epidemic keratoconjunctivitis treatment, visit @ [https://www.delveinsight.com/sample-request/epidemic-keratoconjunctivitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Epidemic keratoconjunctivitis Market Drivers
* Currently, there is no approved therapy for Epidemic keratoconjunctivitis in the market; this might provide good space for emerging therapies in the market
* With the advancement of research and development, new diagnostic tools are being approved for Epidemic keratoconjunctivitis
Epidemic keratoconjunctivitis Market Barriers
* The lack of approved treatment options for Epidemic keratoconjunctivitis offers a great opportunity for the investment and development of novel therapies
* Medications with better safety and effectiveness, which provide an optimum cure, are the current unmet need of the Epidemic keratoconjunctivitis disease market, creating opportunities for the market players to work upon
Scope of the Epidemic keratoconjunctivitis Market Report
* Study Period: 2020-2034
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Epidemic keratoconjunctivitis Companies: Adenovir Pharma AB, and others
* Key Epidemic keratoconjunctivitis Therapies: APD-209 Eye drops, and others
* Epidemic keratoconjunctivitis Therapeutic Assessment: Epidemic keratoconjunctivitis current marketed and Epidemic keratoconjunctivitis emerging therapies
* Epidemic keratoconjunctivitis Market Dynamics: Epidemic keratoconjunctivitis market drivers and Epidemic keratoconjunctivitis market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Epidemic keratoconjunctivitis Unmet Needs, KOL's views, Analyst's views, Epidemic keratoconjunctivitis Market Access and Reimbursement
Discover more about therapies set to grab major Epidemic keratoconjunctivitis market share @ [https://www.delveinsight.com/sample-request/epidemic-keratoconjunctivitis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Table of Contents
1. Epidemic keratoconjunctivitis Market Report Introduction
2. Executive Summary for Epidemic keratoconjunctivitis
3. SWOT analysis of Epidemic keratoconjunctivitis
4. Epidemic keratoconjunctivitis Patient Share (%) Overview at a Glance
5. Epidemic keratoconjunctivitis Market Overview at a Glance
6. Epidemic keratoconjunctivitis Disease Background and Overview
7. Epidemic keratoconjunctivitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Epidemic keratoconjunctivitis
9. Epidemic keratoconjunctivitis Current Treatment and Medical Practices
10. Epidemic keratoconjunctivitis Unmet Needs
11. Epidemic keratoconjunctivitis Emerging Therapies
12. Epidemic keratoconjunctivitis Market Outlook
13. Country-Wise Epidemic keratoconjunctivitis Market Analysis (2020-2034)
14. Epidemic keratoconjunctivitis Market Access and Reimbursement of Therapies
15. Epidemic keratoconjunctivitis Market Drivers
16. Epidemic keratoconjunctivitis Market Barriers
17. Epidemic keratoconjunctivitis Appendix
18. Epidemic keratoconjunctivitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=epidemic-keratoconjunctivitis-treatment-market-2034-ema-pdma-fda-approvals-clinical-trials-therapies-epidemiology-medication-and-companies-by-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epidemic keratoconjunctivitis Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Epidemiology, Medication, and Companies by DelveInsight here
News-ID: 3803001 • Views: …
More Releases from ABNewswire
Oral Surgeon Huntington Beach Practice Elevates Standards for Patient Comfort an …
Huntington Beach oral surgery practice, The Wisdom Teeth Guru sets new patient care standards through specialized training, advanced sedation options, and efficient same-day treatment capabilities under Dr. Kiet Tran's leadership.
A Huntington Beach dental practice has gained recognition for transforming how patients experience oral surgery procedures. The Wisdom Teeth Guru [https://www.google.com/maps/place/The+Wisdom+Teeth+Guru/data=!4m2!3m1!1s0x0:0x98592ab69d239d3a?sa=X&ved=1t:2428&hl=en&ictx=111], led by Dr. Kiet Tran, has established new benchmarks in patient care through advanced techniques and a commitment to making…
Columbus Moving Services Expands as Moving Ahead Services Responds to Central Oh …
Moving Ahead Services expands coverage across 23 Central Ohio communities, offering flexible moving solutions with regulatory compliance and community partnerships that support both residential and commercial relocations.
The Central Ohio region continues to experience steady population growth, and Moving Ahead Services has positioned itself to address the increasing demand for professional relocation assistance. The expansion of Columbus moving services reflects the company's two decades of experience serving the area, with operations…
What Does a Full-Service Move Include? Moving Companies Report Surge in Demand f …
Greenville homeowners increasingly prefer comprehensive relocation packages that handle packing, furniture assembly, transportation, and setup. Professional services reduce stress and damage while streamlining transitions.
Homeowners and renters across Greenville are opting for comprehensive relocation packages as the complexity of modern moves continues to grow. Recent trends show that families and businesses alike are seeking moving companies for an end-to-end solution that eliminates the stress traditionally associated with changing addresses. This shift…
Local Garage Door Company Sees Surge in Emergency Repairs Following Extreme Temp …
AA Garage Door LLC reports increased emergency repairs across St. Paul as extreme cold causes cable failures and spring breaks. Technicians respond to urgent service needs throughout Twin Cities neighborhoods affected by harsh winter conditions.
Recent weather patterns across the St. Paul region have created unprecedented challenges for homeowners, with plummeting temperatures causing significant strain on residential overhead door systems. AA Garage Door LLC, a trusted garage door company [https://maps.google.com/maps?ll=44.91738,-93.190993&z=16&t=h&hl=en&gl=PH&mapclient=embed&cid=15111651982362415047&q=garage+door+company&oq=garage+door+company+near+me] serving…
More Releases for Epidemic
Burnout Epidemic Among High Performers
Brisbane, Australia - [Date] - As burnout rates soar among executives and business leaders, Performance Lab, led by renowned performance coach Tony Wilson, is calling attention to the urgent need for sustainable performance strategies in corporate Australia.
Drawing on three decades of experience coaching elite athletes and Fortune 500 teams, Wilson highlights that over 75% of high performers experience burnout symptoms, risking productivity, engagement, and long-term health. "Our research shows that…
Crofton Chiropractor Sounds Alarm on Tech Neck Epidemic
Crofton, MD - Long hours at desks and endless scrolling are taking a toll on Crofton residents' spines. Dr. Lief Hands, a leading chiropractor in Crofton [https://www.drlhands.com/], says more people than ever are showing up with neck pain, headaches, and lower back problems caused by "tech neck" and poor posture.
Image: https://www.abnewswire.com/upload/2025/09/7956ede9917ab0793be250c0962a2fc7.jpg
"Many people don't realize just how much screen time affects their spine," said Dr. Hands, DC, owner of Precise Chiropractic…
Sober Bar Launches Snusless App to Combat the Zyn Epidemic
Image: https://www.abnewswire.com/upload/2025/09/e8ac4b88ff810718826b0d1565d5d949.jpg
Sober Bar, a company dedicated to creating tools that encourage healthier and more fulfilling lifestyles, has announced the launch of Snusless, a powerful new app designed to help users quit Zyn and other nicotine pouches. The release comes as concerns continue to rise over the "Zyn pandemic," with millions struggling to reduce or eliminate their nicotine usage.
A Smarter Way to Quit Zyn
Snusless is a nicotine pouch and Zyn tracker…
Global Epidemic Insurance Market Forecast 2023-2028 Under Inflation
This Epidemic Insurance market report, further briefs on a wide scope of information for aiding industry players to make its presence in this worldwide market. It likewise catches the impact of monetary set-up on possibilities in key extension sections. This remarkable market study report portrays pertinent market information including new stages, advancements and devices presented on the lookout. This report can be utilized as an ideal apparatus by players to…
Global Epidemic Cerebrospinal Meningitis Vaccines Market Research Report 2023-20 …
Globally, Epidemic Cerebrospinal Meningitis Vaccines key manufacturers include Pfizer, Sanofi Pasteur, GSK, Hulan Bio, Lanzhou Institute of Biological Products, Tianyuan biology, Walvax and Zhifei, etc. Pfizer, Sanofi Pasteur, GSK are top 3 players and held % sales share in total in 2022.
Global Epidemic Cerebrospinal Meningitis Vaccines Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes…
The Mustard Seed Mission Combats Epidemic with Love in Taiwan
26 Children in Agape Children's Home Made Cloth Masks
for themselves and People in Need!
The outbreak of 2019 novel coronavirus (2019-nCoV) has spread worldwide. In Taiwan, from the government to the people, everyone is working hard to prevent infection spread. 26 children in Agape Children's Home of The Mustard Seed Mission made cloth masks by themselves today. From cutting to sewing, and using non-woven fabrics as filter materials, the children made…
